GALDY Financials: Galderma Group AG AI Analysis

Home

Stock

GALDY

Financials

GALDY Financial

Galderma Group AG

$36.61

0.3%

$0.1

As of today:Mar 24, 12:45:01 GMT-4

Overview Forecast Earnings Dividends Financials

Key Stats

Prev.Close

$36.5

Open

$36.44

Day's Range

$36.44 - $36.82

52 week range

$17.27 - $42.93

Volume

5.4K

Avg.Volume

192.1K

Dividend yield

EPS (TTM)

0.32

Market Cap

$42.9B

What is GALDERMA GROUP AG?

Galderma Group AG engages in the provision of science-based premium dermatology solutions. The company is headquartered in Zug, Zug. The company went IPO on 2024-03-22. The Company, throw its subsidiaries, operates a portfolio of carious self-care brands focusing primarily on dermatological solutions, through its subsidiaries. production within the portfolio include neuromodulators, fillers. and biostimulators. these products are designed to relax winkles via injection, fill wrinkles in a specific location via injection and stimulate the body's cells to function optimally. The production process, for the various products primarily takes place in house, form research and development to manufacturing. In addition, including education, scientific engagements, and other services are offered.



Features

AI Copilot for Stock & Crypto

Resources

Market

Income

Balance sheet

Cash flow

Annual

Quarterly

GALDY Income

Financials in millions USD. Fiscal year is February - January.

Breakdown	TTM	12/31/2025	12/31/2024	12/31/2023	12/31/2022	12/31/2021
Revenue	5,241	5,241	4,440	4,116	3,823	3,445
Revenue Growth (YoY)	18%	18%	8%	8%	11%	--
Cost of Revenue	1,627	1,627	1,355	1,231	1,194	1,033
Gross Profit	3,614	3,614	3,085	2,884	2,629	2,411
Selling, General & Admin	2,231	2,196	1,920	1,759	1,698	1,534
Research & Development	245	245	260	286	315	342
Operating Expenses	2,706	2,727	2,410	2,276	2,229	2,061
Other Non Operating Income (Expenses)	-7	-19	6	28	10	-74
Pretax Income	638	638	310	11	-51	-79
Income Tax Expense	26	26	79	68	45	4
Net Income	613	613	231	-57	-98	-156
Net Income Growth	165%	165%	-505%	-42%	-37%	--
Shares Outstanding (Diluted)	236.28	236.99	237.79	237.56	237.56	237.56
Shares Change (YoY)	-1%	0%	0%	0%	0%	--
EPS (Diluted)	2.58	2.58	0.97	-0.24	-0.4	-0.65
EPS Growth	167%	166%	-503%	-41%	-37%	--
Free Cash Flow	1,031	1,031	213	12	-48	67
Free Cash Flow Per Share	--	--	--	--	--	--
Gross Margin	68.95%	68.95%	69.48%	70.06%	68.76%	69.98%
Operating Margin	17.32%	16.92%	15.2%	14.74%	10.46%	10.13%
Profit Margin	11.69%	11.69%	5.2%	-1.38%	-2.56%	-4.52%
Free Cash Flow Margin	19.67%	19.67%	4.79%	0.29%	-1.25%	1.94%
EBITDA	1,231	1,210	968	883	677	602
EBITDA Margin	23.48%	23.08%	21.8%	21.45%	17.7%	17.47%
D&A For EBITDA	323	323	293	276	277	253
EBIT	908	887	675	607	400	349
EBIT Margin	17.32%	16.92%	15.2%	14.74%	10.46%	10.13%
Effective Tax Rate	4.07%	4.07%	25.48%	618.18%	-88.23%	-5.06%

Follow-Up Questions

What are Galderma Group AG's key financial statements?



According to the latest financial statement (Form-10K), Galderma Group AG has a total asset of $13,393, Net profit of $613

What are the key financial ratios for GALDY?



Galderma Group AG's Current ratio is 2.55, has a Net margin is 11.69, sales per share of $22.11.

How is Galderma Group AG's revenue broken down by segment or geography?



Galderma Group AG largest revenue segment is Other, at a revenue of 35,000,000 in the most earnings release.For geography, USA is the primary market for Galderma Group AG, at a revenue of 2,231,000,000.

Is Galderma Group AG profitable?



yes, according to the latest financial statements, Galderma Group AG has a net profit of $613

Does Galderma Group AG have any liabilities?



yes, Galderma Group AG has liability of 5,244

How many outstanding shares for Galderma Group AG?



Galderma Group AG has a total outstanding shares of 234.56

Galderma Group AG (GALDY) Financial

GALDY Stock Price Chart